 4. Inadequate response, relapse, andor unacceptable toxicity with one or more prior systemic, surgical, or radiation cancer therapies, and for whom curative standard therapy is not an option except patients with NSCLC who must have experienced either an inadequate response, relapse, andor unacceptable toxicity with two or more prior systemic, surgical, or radiation cancer therapies 